compound 33 [Toda et al., 2013]   Click here for help

GtoPdb Ligand ID: 8791

Compound class: Synthetic organic
Comment: Compound 33 is reported as a GPR142 agonist and provides evidence to support the hypothesis that GPR142 agonists act as insulin secretagogues, which could eventually lead to the discovery of novel treatments for type 2 diabetes mellitus [1].
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 8
Hydrogen bond donors 1
Rotatable bonds 9
Topological polar surface area 102.47
Molecular weight 438.25
XLogP 2.17
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES CCOCc1c(cnn1c1ncc(c(n1)N1CCCCC1)C)C(=O)NCc1cncn1C
Isomeric SMILES CCOCc1c(cnn1c1ncc(c(n1)N1CCCCC1)C)C(=O)NCc1cncn1C
InChI InChI=1S/C22H30N8O2/c1-4-32-14-19-18(21(31)24-12-17-11-23-15-28(17)3)13-26-30(19)22-25-10-16(2)20(27-22)29-8-6-5-7-9-29/h10-11,13,15H,4-9,12,14H2,1-3H3,(H,24,31)
InChI Key ATOKVTDUHKZLMB-UHFFFAOYSA-N
References
1. Toda N, Hao X, Ogawa Y, Oda K, Yu M, Fu Z, Chen Y, Kim Y, Lizarzaburu M, Lively S et al.. (2013)
Potent and Orally Bioavailable GPR142 Agonists as Novel Insulin Secretagogues for the Treatment of Type 2 Diabetes.
ACS Med Chem Lett, 4 (8): 790-4. [PMID:24900747]